A new study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2.
from All Top News -- ScienceDaily https://ift.tt/3qA3YQo
from All Top News -- ScienceDaily https://ift.tt/3qA3YQo
Comments
Post a Comment